These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 25228385

  • 1. miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer.
    Tan X, Peng J, Fu Y, An S, Rezaei K, Tabbara S, Teal CB, Man YG, Brem RF, Fu SW.
    Breast Cancer Res; 2014 Sep 17; 16(5):435. PubMed ID: 25228385
    [Abstract] [Full Text] [Related]

  • 2. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X, Fu Y, Chen L, Lee W, Lai Y, Rezaei K, Tabbara S, Latham P, Teal CB, Man YG, Siegel RS, Brem RF, Fu SW.
    Oncotarget; 2016 Jan 05; 7(1):293-307. PubMed ID: 26588055
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.
    Matamala N, Vargas MT, González-Cámpora R, Arias JI, Menéndez P, Andrés-León E, Yanowsky K, Llaneza-Folgueras A, Miñambres R, Martínez-Delgado B, Benítez J.
    Oncotarget; 2016 Apr 12; 7(15):20068-79. PubMed ID: 26933805
    [Abstract] [Full Text] [Related]

  • 4. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B, Majid S, Ursu S, de Semir D, Nosrati M, Bezrookove V, Kashani-Sabet M, Dar AA.
    Oncotarget; 2016 Apr 12; 7(15):19519-30. PubMed ID: 26799586
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL, Zhang ZJ, Yi ZB, Li JJ.
    Br J Cancer; 2017 Jun 27; 117(1):78-88. PubMed ID: 28571042
    [Abstract] [Full Text] [Related]

  • 6. PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer.
    Song W, Tang L, Xu Y, Xu J, Zhang W, Xie H, Wang S, Guan X.
    Sci Rep; 2017 Feb 08; 7():42319. PubMed ID: 28176879
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z, Meng Q, Pan A, Wu X, Cui J, Wang Y, Li L.
    Oncotarget; 2017 Mar 21; 8(12):19455-19466. PubMed ID: 28038450
    [Abstract] [Full Text] [Related]

  • 8. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC, Wang JX, Han ML, Zhang LP, Li L.
    Cell Oncol (Dordr); 2017 Apr 21; 40(2):157-166. PubMed ID: 28054302
    [Abstract] [Full Text] [Related]

  • 9. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J, Lai Y, Ma J, Liu Y, Bi J, Zhang L, Chen L, Yao C, Lv W, Chang G, Wang S, Ouyang M, Wang W.
    BMC Cancer; 2017 Nov 10; 17(1):745. PubMed ID: 29126392
    [Abstract] [Full Text] [Related]

  • 10. Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer.
    Tang T, Cheng Y, She Q, Jiang Y, Chen Y, Yang W, Li Y.
    Biomed Pharmacother; 2018 Nov 10; 107():338-346. PubMed ID: 30098551
    [Abstract] [Full Text] [Related]

  • 11. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer.
    Wu J, Xu W, Ma L, Sheng J, Ye M, Chen H, Zhang Y, Wang B, Liao M, Meng T, Zhou Y, Chen H.
    Aging (Albany NY); 2021 Jul 21; 13(14):18191-18222. PubMed ID: 34289449
    [Abstract] [Full Text] [Related]

  • 12. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
    Li YY, Zheng XH, Deng AP, Wang Y, Liu J, Zhou Q, Cheng GY, Jiang Q.
    Eur Rev Med Pharmacol Sci; 2019 Dec 21; 23(23):10433-10442. PubMed ID: 31841197
    [Abstract] [Full Text] [Related]

  • 13. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
    Ji H, Sang M, Liu F, Ai N, Geng C.
    Pathol Res Pract; 2019 Apr 21; 215(4):697-704. PubMed ID: 30611621
    [Abstract] [Full Text] [Related]

  • 14. Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancers.
    Domagala P, Hybiak J, Rys J, Byrski T, Cybulski C, Lubinski J.
    Oncotarget; 2016 Oct 18; 7(42):68662-68673. PubMed ID: 27626685
    [Abstract] [Full Text] [Related]

  • 15. LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication.
    Sheng X, Dai H, Du Y, Peng J, Sha R, Yang F, Zhou L, Lin Y, Xu S, Wu Y, Yin W, Lu J.
    J Exp Clin Cancer Res; 2021 Jun 23; 40(1):205. PubMed ID: 34162418
    [Abstract] [Full Text] [Related]

  • 16. RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence.
    Haynes B, Gajan A, Nangia-Makker P, Shekhar MP.
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan 01; 1866(1):165561. PubMed ID: 31639439
    [Abstract] [Full Text] [Related]

  • 17. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer.
    Guo SJ, Zeng HX, Huang P, Wang S, Xie CH, Li SJ.
    Eur Rev Med Pharmacol Sci; 2018 Oct 01; 22(19):6379-6385. PubMed ID: 30338806
    [Abstract] [Full Text] [Related]

  • 18. Transcriptionally regulated miR-26a-5p may act as BRCAness in Triple-Negative Breast Cancer.
    Zhang Y, Lv L, Zheng R, Xie R, Yu Y, Liao H, Chen J, Zhang B.
    Breast Cancer Res; 2023 Jun 26; 25(1):75. PubMed ID: 37365643
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD.
    Song H, Li D, Wu T, Xie D, Hua K, Hu J, Deng X, Ji C, Deng Y, Fang L.
    BMB Rep; 2018 Nov 26; 51(11):602-607. PubMed ID: 30269739
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-543 inhibits the proliferation, migration, invasion, and epithelial-mesenchymal transition of triple-negative breast cancer cells via down-regulation of ACTL6A gene.
    Wang YL, Liang RH, Wang CY, Zhang RP, Wu SY, Han X, Zhang GL.
    Clin Transl Oncol; 2022 Jan 26; 24(1):84-92. PubMed ID: 34181232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.